Scynexis (SCYX) Research & Development (2013 - 2026)
Scynexis (SCYX) reported Research & Development of $12.4 million for Q1 2026, up 140.25% on a YoY basis from $5.1 million in Q1 2025, and up 171.75% quarter-over-quarter from $4.5 million in Q4 2025.
Scynexis (SCYX) Research & Development (2013 - 2026) Analysis & Trends
Scynexis has reported Research & Development for 14 years, with the latest figure at $12.4 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 140.25% year-over-year to $12.4 million; the trailing twelve-month figure through Mar 2026 stood at $29.5 million (up 21.18% YoY), and the FY2025 full-year result was $22.3 million, down 15.62% from the prior year.
- Research & Development for Q1 2026 stood at $12.4 million, up from $4.5 million in the prior quarter.
- The five-year high for Research & Development was $12.4 million in Q1 2026, with the low at $4.3 million in Q4 2024.
- Historically, Research & Development has averaged $7.0 million across 5 years, with a median of $6.8 million in 2023.
- Annual changes were most pronounced in 2024 — Research & Development slumped 59.25% — and 2026, when it surged 140.25%.
- Scynexis' Research & Development stood at $7.8 million in 2022, then surged by 34.87% to $10.6 million in 2023, then tumbled by 59.25% to $4.3 million in 2024, then climbed by 5.35% to $4.5 million in 2025, then soared by 171.75% to $12.4 million in 2026.
- The last three Research & Development figures came in at $12.4 million (Q1 2026), $4.5 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 46.94 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 39.38 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 12.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.35 Mn |
| Dec 31, 2025 | 4.55 Mn |
| Sep 30, 2025 | 5.45 Mn |
| Jun 30, 2025 | 7.14 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Dec 31, 2024 | 4.31 Mn |
| Sep 30, 2024 | 8.07 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Mar 31, 2024 | 7.21 Mn |
| Dec 31, 2023 | 10.59 Mn |
| Sep 30, 2023 | 6.47 Mn |
| Jun 30, 2023 | 7.04 Mn |
| Mar 31, 2023 | 6.84 Mn |
| Dec 31, 2022 | 7.85 Mn |
| Sep 30, 2022 | 6.43 Mn |
| Jun 30, 2022 | 7.13 Mn |
| Mar 31, 2022 | 5.74 Mn |
| Dec 31, 2021 | 7.69 Mn |
| Sep 30, 2021 | 4.40 Mn |
| Jun 30, 2021 | 4.73 Mn |